LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
November 25, 2025
Lucid Diligence Brief: Sprint Bioscience sells TREX1 program to Gilead
November 25, 2025
Endocrinology Today—November 25, 2025
November 25, 2025
Lucid Diligence Brief: Vaximm VXM01 License Term Sheet with BCM Europe
November 25, 2025
Obesity Video Recap—November 25, 2025
November 25, 2025
Obesity Today—November 25, 2025
November 24, 2025
Hematology Today—November 24, 2025
November 24, 2025
Oncology Video Recap—November 24, 2025
November 24, 2025
Oncology Today—November 24, 2025
November 24, 2025
AI in Healthcare and Digital Health Today—November 24, 2025
November 24, 2025
Lucid Diligence Brief: Aspen Neuroscience $115M Series C
November 23, 2025